September 12, 2017 – Pritzker Levine LLP partner Elizabeth C. Pritzker has been appointed as the Chair of the Plaintiffs’ Steering Committee in the pending multidistrict class action litigation alleging that Mylan, the maker of the EpiPen, engaged in monopolization and other violations of state antitrust and consumer protection laws.
In re EpiPen (Epinephrine Injector, USP) Marketing, Sales Practices and Antitrust Litigation is pending in the United States District Court for the District of Kansas.
About Pritzker Levine
Pritzker Levine LLP is national litigation firm with offices in California and New York. The firm serves corporate clients, public entities, pension funds, small businesses, nonprofit groups, labor unions, whistleblowers and injured persons in cases involving antitrust violations, securities fraud and derivative claims, commercial disputes, consumer protection, financial wrongdoing, employment law and personal injuries.